Recent Advances in Single-Cell Profiling and Multispecific Therapeutics: Paving the Way for a New Era of Precision Medicine Targeting Cardiac Fibroblasts.

Shi, Sally Yu; Luo, Xin; Yamawaki, Tracy M; Li, Chi-Ming; Ason, Brandon; Furtado, Milena B

Shi, Sally Yu; Luo, Xin; Yamawaki, Tracy M; Li, Chi-Ming; Ason, Brandon; Furtado, Milena B.

Affiliation

Shi SY; Department of Cardiometabolic Disorders, Amgen Discovery Research, Amgen Inc., 1120 Veterans Blvd, South San Francisco, CA, 94080, USA. sshi01@amgen.com.
Luo X; Genome Analysis Unit, Amgen Discovery Research, Amgen Inc., 1120 Veterans Blvd, South San Francisco, CA, 94080, USA.
Yamawaki TM; Genome Analysis Unit, Amgen Discovery Research, Amgen Inc., 1120 Veterans Blvd, South San Francisco, CA, 94080, USA.
Li CM; Genome Analysis Unit, Amgen Discovery Research, Amgen Inc., 1120 Veterans Blvd, South San Francisco, CA, 94080, USA.
Ason B; Department of Cardiometabolic Disorders, Amgen Discovery Research, Amgen Inc., 1120 Veterans Blvd, South San Francisco, CA, 94080, USA.
Furtado MB; Department of Cardiometabolic Disorders, Amgen Discovery Research, Amgen Inc., 1120 Veterans Blvd, South San Francisco, CA, 94080, USA. mfurtado@amgen.com.

Curr Cardiol Rep ; 23(7): 82, 2021 06 03.

Article de En | MEDLINE | ID: mdl-34081224

Sujet(s)
Mots clés

Cardiac fibroblasts; Cardiac fibrosis; Heart failure; Multispecific therapeutics; Precision medicine; Single-cell RNA-sequencing

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Médecine de précision / Myocarde Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Curr Cardiol Rep Sujet du journal: CARDIOLOGIA Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google